These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30991456)

  • 1. Translational drug discovery and development with the use of tissue-relevant biomarkers: Towards more physiological relevance and better prediction of clinical efficacy.
    Florian P; Flechsenhar KR; Bartnik E; Ding-Pfennigdorff D; Herrmann M; Bryce PJ; Nestle FO
    Exp Dermatol; 2020 Jan; 29(1):4-14. PubMed ID: 30991456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo pharmacological disease models for psoriasis and atopic dermatitis in drug discovery.
    Petersen TK
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):104-15. PubMed ID: 16918710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational dermatology in drug discovery: perspectives for integrating humanized xenograft models and experimental clinical studies.
    Petersen TK; Sørensen P
    Drug Discov Today; 2008 Mar; 13(5-6):240-6. PubMed ID: 18342800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis drug discovery: methods for evaluation of potential drug candidates.
    Svensson L; Røpke MA; Norsgaard H
    Expert Opin Drug Discov; 2012 Jan; 7(1):49-61. PubMed ID: 22468893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic and pharmacological assessment of murine IL-23 mediated psoriasiform dermatitis; implications for drug discovery.
    Gauld SB; Gauvin D; Olson L; Leys L; Paulsboe S; Liu Z; Edelmayer RM; Wetter J; Salte K; Wang Y; Huang S; Honore P; McGaraughty S
    J Dermatol Sci; 2018 Oct; 92(1):45-53. PubMed ID: 30149967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies for the treatment of atopic dermatitis.
    Renert-Yuval Y; Guttman-Yassky E
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):356-364. PubMed ID: 29870461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's new in the treatment of atopic dermatitis?
    Dattola A; Bennardo L; Silvestri M; Nisticò SP
    Dermatol Ther; 2019 Mar; 32(2):e12787. PubMed ID: 30548724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine models of psoriasis and their usefulness for drug discovery.
    Chuang SY; Lin CH; Sung CT; Fang JY
    Expert Opin Drug Discov; 2018 Jun; 13(6):551-562. PubMed ID: 29663834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.
    Sun L; Liu W; Zhang LJ
    J Immunol Res; 2019; 2019():1824624. PubMed ID: 31815151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dupilumab: a revolutionary emerging drug in atopic dermatitis and its possible role in pemphigus.
    Tavakolpour S
    Dermatol Ther; 2016 Sep; 29(5):299. PubMed ID: 26800435
    [No Abstract]   [Full Text] [Related]  

  • 11. Protein tyrosine phosphatase conjugated with a novel transdermal delivery peptide, astrotactin 1-derived peptide recombinant protein tyrosine phosphatase (AP-rPTP), alleviates both atopic dermatitis-like and psoriasis-like dermatitis.
    Kim WJ; Koo JH; Cho HJ; Lee JU; Kim JY; Lee HG; Lee S; Kim JH; Oh MS; Suh M; Shin EC; Ko JY; Sohn MH; Choi JM
    J Allergy Clin Immunol; 2018 Jan; 141(1):137-151. PubMed ID: 28456618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into the biomarkers as the novel anti-psoriatic drug discovery tool: a contemporary viewpoint.
    Rahman M; Zaki Ahmad M; Kazmi I; Akhter S; Beg S; Gupta G; Afzal M; Saleem S; Ahmad I; Adil Shaharyar M; Jalees Ahmed F; Anwar F
    Curr Drug Discov Technol; 2012 Mar; 9(1):48-62. PubMed ID: 22023258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved clinical outcomes with moisturization in dermatologic disease.
    Ghali FE
    Cutis; 2005 Dec; 76(6 Suppl):13-8. PubMed ID: 16869177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers.
    He H; Olesen CM; Pavel AB; Clausen ML; Wu J; Estrada Y; Zhang N; Agner T; Guttman-Yassky E
    Front Immunol; 2020; 11():1768. PubMed ID: 32849633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo culture of lesional psoriasis skin for pharmacological testing.
    Tiirikainen ML; Woetmann A; Norsgaard H; Santamaria-Babí LF; Lovato P
    J Dermatol Sci; 2020 Feb; 97(2):109-116. PubMed ID: 31948839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel therapies based on the pathophysiology of atopic dermatitis.
    Bieber T
    J Dtsch Dermatol Ges; 2019 Nov; 17(11):1150-1162. PubMed ID: 31765104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of IL-23 Pharmacokinetics by Highly Sensitive Accelerator Mass Spectrometry and Subsequent Modeling to Project IL-23 Suppression in Psoriasis Patients Treated with Anti-IL-23 Antibodies.
    Zhang TT; Ma J; Durbin KR; Montavon T; Lacy SE; Jenkins GJ; Doktor S; Kalvass JC
    AAPS J; 2019 Jun; 21(5):82. PubMed ID: 31250228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exacerbation of atopic dermatitis symptoms by ustekinumab in psoriatic patients with elevated serum immunoglobulin E levels: Report of two cases.
    Ishiuji Y; Umezawa Y; Asahina A; Fukuta H; Aizawa N; Yanaba K; Nakagawa H
    J Dermatol; 2018 Jun; 45(6):732-734. PubMed ID: 29569296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases.
    Kaufman BP; Alexis AF
    Curr Allergy Asthma Rep; 2018 Aug; 18(10):55. PubMed ID: 30171358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atopic-like dermatitis after secukinumab injection: A case report.
    Burlando M; Cozzani E; Russo R; Parodi A
    Dermatol Ther; 2019 Jan; 32(1):e12751. PubMed ID: 30238583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.